The effect of rebamipide on non-steroidal anti-inflammatory drug-induced gastro-enteropathy: a multi-center, randomized pilot study
Dong Jun Oh, Hyuk Yoon, Hyun Soo Kim, Yoon Jin Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, You-Jung Ha, Eun Ha Kang, Yun Jong Lee, Nayoung Kim, Ki-Jeoung Kim, Fei Liu
Korean J Intern Med. 2022;37(6):1153-1166. Published online 2022 Nov 1 DOI: https://doi.org/10.3904/kjim.2021.216
Citations to this article as recorded by 
Rebamipide during chronic gastritis: H. pylori eradication therapy and restoration of gastric mucosa barrier function
ΠΆ. L. Lapina, V. T. Ivashkin
Russian Journal of Gastroenterology, Hepatology, Coloproctology.2024; 33(6): 81. CrossRef
Berberine mitigates diclofenac-induced intestinal mucosal mechanical barrier dysfunction through the restoration of autophagy by inhibiting exosome-mediated lncRNA H19
Ruonan He, Ying Li, Yi He, Qianqian Wang, Shuo Zhang, Shanshan Chen
Inflammopharmacology.2024; 32(4): 2525. CrossRef
DA-9601 has protective effects comparable to those of proton pump inhibitor and rebamipide against nonsteroidal anti-inflammatory drugs-induced upper and lower gastrointestinal bleeding in patients with rheumatoid arthritis: A nationwide study using Korea
Min Wook So, Aran Kim, Seung-Geun Lee
Medicine.2024; 103(27): e38801. CrossRef
Technology Criteria for the Manufacturing of Rebamipide Film-coated Tablets
G. V. Trusov, B. V. Brovchenko, Z. M. Kozlova, I. I. Krasnyuk
Drug development & registration.2023;[Epub] CrossRef